E64d, a cathepsin L inhibitor, significantly inhibits endosomal SARS-CoV-2 infection mainly in the absence of TMPRSS2 while camostat, a serine-protease-inhibitor, inhibits membrane-fusion-mediated infection in the TMPRSS2 positive cells10. This evidence concerns the gene TMPRSS2 and infection.